Cargando…

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108

The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) has raised healthcare concerns worldwide. VISA is often associated with multiple genetic changes. However, the relative contributions of these changes to VISA phenotypes are incompletely defined. We have characterized VISA XN108 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Huagang, Rao, Yifan, Yuan, Wenchang, Zheng, Ying, Shang, Weilong, Hu, Zhen, Yang, Yi, Tan, Li, Xiong, Kun, Li, Shu, Zhu, Junmin, Hu, Xiaomei, Hu, Qiwen, Rao, Xiancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279853/
https://www.ncbi.nlm.nih.gov/pubmed/30546356
http://dx.doi.org/10.3389/fmicb.2018.02955
_version_ 1783378552873287680
author Peng, Huagang
Rao, Yifan
Yuan, Wenchang
Zheng, Ying
Shang, Weilong
Hu, Zhen
Yang, Yi
Tan, Li
Xiong, Kun
Li, Shu
Zhu, Junmin
Hu, Xiaomei
Hu, Qiwen
Rao, Xiancai
author_facet Peng, Huagang
Rao, Yifan
Yuan, Wenchang
Zheng, Ying
Shang, Weilong
Hu, Zhen
Yang, Yi
Tan, Li
Xiong, Kun
Li, Shu
Zhu, Junmin
Hu, Xiaomei
Hu, Qiwen
Rao, Xiancai
author_sort Peng, Huagang
collection PubMed
description The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) has raised healthcare concerns worldwide. VISA is often associated with multiple genetic changes. However, the relative contributions of these changes to VISA phenotypes are incompletely defined. We have characterized VISA XN108 with vancomycin MIC of 12 μg/ml. Genome comparison revealed that WalK(S221P), GraS(T136I), and RpoB(H481N) mutations possibly contributed to the VISA phenotype of XN108. In this study, the above mutations were stepwise cured, and the phenotypes between XN108 and its derivates were compared. We constructed four isogenic mutant strains, XN108-WalK(P221S) (termed as K65), XN108-GraS(I136T) (termed as S65), XN108-RpoB(N481H) (termed as B65), and XN108-WalK(P221S)/GraS(I136T) (termed as KS65), using the allelic replacement experiments with the native alleles derived from a vancomycin-susceptible S. aureus isolate DP65. Antimicrobial susceptibility test revealed K65 and S65 exhibited decreased vancomycin resistance, whereas B65 revealed negligibly differed when compared with the wild-type XN108. Sequentially introducing WalK(P221S) and GraS(I136T) completely converted XN108 into a VSSA phenotype. Transmission electronic microscopy and autolysis determination demonstrated that cell wall thickening and decreasing autolysis were associated with the change of vancomycin resistance levels. Compared with XN108, K65 exhibited 577 differentially expressed genes (DEGs), whereas KS65 presented 555 DEGs. Of those DEGs, 390 were common in K65 and KS65, including those upregulated genes responsible for citrate cycle and bacterial autolysis, and the downregulated genes involved in peptidoglycan biosynthesis and teichoic acid modification. In conclusion, a VSSA phenotype could be completely reconstituted from a VISA strain XN108. WalK(S221P) and GraS(T136I) mutations may work synergistically in conferring vancomycin resistance in XN108.
format Online
Article
Text
id pubmed-6279853
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62798532018-12-13 Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108 Peng, Huagang Rao, Yifan Yuan, Wenchang Zheng, Ying Shang, Weilong Hu, Zhen Yang, Yi Tan, Li Xiong, Kun Li, Shu Zhu, Junmin Hu, Xiaomei Hu, Qiwen Rao, Xiancai Front Microbiol Microbiology The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) has raised healthcare concerns worldwide. VISA is often associated with multiple genetic changes. However, the relative contributions of these changes to VISA phenotypes are incompletely defined. We have characterized VISA XN108 with vancomycin MIC of 12 μg/ml. Genome comparison revealed that WalK(S221P), GraS(T136I), and RpoB(H481N) mutations possibly contributed to the VISA phenotype of XN108. In this study, the above mutations were stepwise cured, and the phenotypes between XN108 and its derivates were compared. We constructed four isogenic mutant strains, XN108-WalK(P221S) (termed as K65), XN108-GraS(I136T) (termed as S65), XN108-RpoB(N481H) (termed as B65), and XN108-WalK(P221S)/GraS(I136T) (termed as KS65), using the allelic replacement experiments with the native alleles derived from a vancomycin-susceptible S. aureus isolate DP65. Antimicrobial susceptibility test revealed K65 and S65 exhibited decreased vancomycin resistance, whereas B65 revealed negligibly differed when compared with the wild-type XN108. Sequentially introducing WalK(P221S) and GraS(I136T) completely converted XN108 into a VSSA phenotype. Transmission electronic microscopy and autolysis determination demonstrated that cell wall thickening and decreasing autolysis were associated with the change of vancomycin resistance levels. Compared with XN108, K65 exhibited 577 differentially expressed genes (DEGs), whereas KS65 presented 555 DEGs. Of those DEGs, 390 were common in K65 and KS65, including those upregulated genes responsible for citrate cycle and bacterial autolysis, and the downregulated genes involved in peptidoglycan biosynthesis and teichoic acid modification. In conclusion, a VSSA phenotype could be completely reconstituted from a VISA strain XN108. WalK(S221P) and GraS(T136I) mutations may work synergistically in conferring vancomycin resistance in XN108. Frontiers Media S.A. 2018-11-28 /pmc/articles/PMC6279853/ /pubmed/30546356 http://dx.doi.org/10.3389/fmicb.2018.02955 Text en Copyright © 2018 Peng, Rao, Yuan, Zheng, Shang, Hu, Yang, Tan, Xiong, Li, Zhu, Hu, Hu and Rao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Peng, Huagang
Rao, Yifan
Yuan, Wenchang
Zheng, Ying
Shang, Weilong
Hu, Zhen
Yang, Yi
Tan, Li
Xiong, Kun
Li, Shu
Zhu, Junmin
Hu, Xiaomei
Hu, Qiwen
Rao, Xiancai
Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title_full Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title_fullStr Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title_full_unstemmed Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title_short Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
title_sort reconstruction of the vancomycin-susceptible staphylococcus aureus phenotype from a vancomycin-intermediate s. aureus xn108
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279853/
https://www.ncbi.nlm.nih.gov/pubmed/30546356
http://dx.doi.org/10.3389/fmicb.2018.02955
work_keys_str_mv AT penghuagang reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT raoyifan reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT yuanwenchang reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT zhengying reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT shangweilong reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT huzhen reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT yangyi reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT tanli reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT xiongkun reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT lishu reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT zhujunmin reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT huxiaomei reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT huqiwen reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108
AT raoxiancai reconstructionofthevancomycinsusceptiblestaphylococcusaureusphenotypefromavancomycinintermediatesaureusxn108